GSK Gsk Plc

TIDMGSK

RNS Number : 9136N

GlaxoSmithKline PLC

23 January 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================== 
 a)   Name                     Mr B McNamara 
===  ========================  ================================================ 
 b)   Position/status          CEO, GSK Consumer Healthcare 
===  ========================  ================================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ================================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ================================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ================================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of            American Depositary Shares ('ADSs') 
       the financial 
       instrument                ISIN: US37733W1053 
===  ========================  ================================================ 
 b)   Nature of the            The vesting of an award over 8,994 ADSs 
       transaction              made under the GlaxoSmithKline Share Value 
                                Plan. Of the vested award, 4,430 ADSs were 
                                automatically withheld to meet tax liabilities. 
===  ========================  ================================================ 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                            ---------- 
                                  $38.70     8,994 
                                            ---------- 
===  ========================  ================================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ================================================ 
 e)   Date of the transaction  2019-01-22 
===  ========================  ================================================ 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  ================================================ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHXXLFLKFFBBBZ

(END) Dow Jones Newswires

January 23, 2019 08:10 ET (13:10 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024